Lupin Ltd

LUPIN14 Jun 2024
Pharmaceuticals
-1.35 (-0.08%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Lupin
Lupin Ltd
Pharmaceuticals
LUPIN14 Jun 2024
-1.35 (-0.08%)
1D
1M
6M
1Y
5Y
All

Lupin - Share Price & Details

Lowest Today
1596.55
Highest Today
1615
Today’s Open
1614
Prev. Close
1605.45
52 Week High
1728
52 Week Low
821.6
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
95.92%
Upper Circuit
Lower Circuit
P/E TTM
31.42
P/B Ratio
3.55
Traded Value(Cr)
0.00
EPS TTM
51.04
Book value
Dividend
0.50%

Price Performance

-1.56 %
1 Wk
-2.02 %
1 M
-2.76 %
3 M
95.92 %
1 Y
22.18 %
YTD

Traded Volume Movement

Technical Details

Support 3
1577
Support 2
1587
Support 1
1596
Pivot Point :
1606
Resistance 1
1614
Resistance 2
1624
Resistance 3
1633

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Lupin Ltd
₹1,604.10(-1.35/-0.08%)
1,604.10-1.3573,106.8795.9231.423.55
J B Chemicals & Pharmaceuticals Ltd
₹1,854.30(-31.05/-1.65%)
1,854.30-31.0528,781.1670.3552.969.97
Ipca Laboratories Ltd
₹1,181.35(-18.45/-1.54%)
1,181.35-18.4529,971.3564.8048.674.73
Brooks Laboratories Ltd
₹85.63(+3.19/3.87%)
85.63+3.19224.7538.87145.903.19
Sanofi India Ltd
₹6,838.70(+325.65/5.00%)
6,838.70+325.6515,749.53-0.8427.7515.51
408.95+20.302,400.76-8.8717.721.49

About Lupin Ltd

Lupin Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 73095.48 crores. It has reported a sales of Rs. 3331.72 crores and a net profit of Rs. 384.08 crores for the quarter ended December 2018. The company management includes M D Gupta, M D Gupta,Nilesh Deshbandhu Gupta.,Vinita Gupta,R V Satam,Jean-Luc Belingard,Ramesh Swaminathan,Mark D McDade,K B S Anand,Punita Kumar Sinha (Lupin Ltd) among others.
Chairman
M D Gupta
Registered office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai,Maharashtra,400055
FAX :91-22-6640 8131
Background
Incorporation Year1983
Face Value₹2
Market Lot1

Latest News

Broader market logs best two-week gains in 3 years
The Indian stock market has seen a significant surge, with the BSE midcap index rising 7.5% and the BSE smallcap index rising 8.3% in two weeks, driven by strong inflows from retail investors and foreign portfolio investors. The benchmark indices, Nifty and Sensex, have also risen over 4% each, with the market capitalization of BSE-listed companies hitting a record high of Rs 429.32 lakh crore.
15 Jun 2024 | 02:52 PM
Nearly 200 smallcaps give double digit return
Indian markets rose for the second consecutive week, with the BSE Sensex gaining 299.41 points (0.39%) to 76,992.77 and the Nifty50 index rising 175.45 points (0.75%) to 23,465.60. Foreign institutional investors bought equities worth Rs 2,030.83 crore, while domestic institutional investors bought Rs 6,293.38 crore. The BSE Small-cap index surged 5% to a record high of 51,259.06.
15 Jun 2024 | 01:33 PM
Broader market logs best two-week gains in 3 years
The Indian stock market has seen a significant surge, with the BSE midcap index rising 7.5% and the BSE smallcap index rising 8.3% in two weeks, driven by strong inflows from retail investors and foreign portfolio investors. The benchmark indices, Nifty and Sensex, have also risen over 4% each, with the market capitalization of BSE-listed companies hitting a record high of Rs 429.32 lakh crore.
15 Jun 2024 | 02:52 PM
Nearly 200 smallcaps give double digit return
Indian markets rose for the second consecutive week, with the BSE Sensex gaining 299.41 points (0.39%) to 76,992.77 and the Nifty50 index rising 175.45 points (0.75%) to 23,465.60. Foreign institutional investors bought equities worth Rs 2,030.83 crore, while domestic institutional investors bought Rs 6,293.38 crore. The BSE Small-cap index surged 5% to a record high of 51,259.06.
15 Jun 2024 | 01:33 PM
CMI Q2 Results: loss falls by 75.01% YOY
CMI reported Q2 results, with a 230.59% increase in topline and 75.01% decrease in loss YoY. Revenue grew 95.34% QoQ, with operating income up 51.29% QoQ and 48.56% YoY. EPS was ₹-1.15, up 81.22% YoY. The company has a market cap of ₹8.01 Cr and has delivered -13.79% return in the last 6 months and -17.36% YTD return.
15 Jun 2024 | 03:37 PM

How to buy Lupin shares on nse?

To buy Lupin shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lupin share price today?

The Lupin shares price on nse is Rs.1604.1 today.

What is the market cap of Lupin shares on NSE ?

The company has a market capitalization of Rs.73106.87Cr

What is the PE & PB ratio of Lupin shares ?

PE is 31.42 and PB is 3.55

What is the 52 Week High and Low of Lupin shares?

Lupin stock price high: Rs.1728 Lupin stock price low: Rs.821.6

What can be the price of Lupin stocks on BSE?

As of 13:15 hours on 12th May 2023, the stock price of Lupin on the BSE was rupees 773. The price fluctuates constantly throughout trading hours. So, check for the updated price when you invest.

Is it safe to buy Lupin stocks?

Lupin is a leading name in the pharmaceutical sector. It has a market capitalization of rupees 34,804.93 crores with an average trading volume of 61,434.45. The stock might suffer price fluctuations in the short-run depending on market movements. However, the stock price might appreciate and give good returns over the long term. So, it is safe to invest in Lupin if you have a long-term horizon.

What is the current market value per stock of Lupin stocks?

As of 13:15 hours on 12th May 2023, the current market value is rupees 773 on the BSE and rupees 773.10 on the NSE.

Does Lupin have any debts?

Yes, Lupin has debt in its balance sheet. As of 31st March 2023, Lupin had secured loans worth rupees 613.46 crores.

Will Lupin's stock price increase?

While Lupin is trading at rupees 773 on 12th May 2023, its lower circuit is quoted at rupees 688.45, and the upper circuit is at rupees 841.35. Considering the upper circuit, the company’s stock price is expected to increase. Moreover, if you stay invested over a long-term horizon, you can witness a gain in the stock price as the short-term volatilities smoothen out and the company grows.

What is the business plan of Lupin?

Lupin aims to expand its domestic and international business with increased manufacturing of its popular drugs. The company specifically targeted growth in the US and China which would boost its revenue and profitability.